• with H. Källberg et al.:
Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis,
American J. Hum. Genetics, Vol. 80, 2007, pp. 867-875 • with E.F. Remmers et al.:
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. In:
New England Journal of Medicine, Vol. 357, 2007, pp. 977-986. • with J. Rönnelid, K. Lundberg et al.:
Immunity to citrullinated proteins in rheumatoid arthritis . In:
Annual Review of Immunology , Vol. 26, 2008, pp. 651-675. • with A. C. Catrina & S. Paget:
Rheumatoid arthritis (seminar). In:
The Lancet , Volume 373, 2009 pp. 659-672 • with H. Mahdi et al.:
Specific Interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. In:
Nature Genetics , Vol. 41, 2009, pp. 1319-1324 • with S. Saevarsdottir et al.:
Patients with early rheumatoid arthritis who smoke are less likely to respond to methotrexate and TNF inhibitors. Observations from the EIRA cohort and the Swedish Rheumatology Register . In:
Arthritis & Rheumatism , January 2011. • with L Mathsson, M Mullazehi, MC Wick, O Sjöberg, et al .:
Antibodies against citrullinated vimentin in rheumatoid arthritis: Higher sensitivity and extended prognostic value concerning future radiographic progression as compared with cyclic citrullinated peptides. In:
Arthritis Rheum, 2007, 58 (1), pp. 36-45 ==References==